Initial data showed promising signs of efficacy, including a 47.1% ORR in patients with resistant/refractory gastric cancer expressing Claudin 18.2, with a well-tolerated safety profile Elevation...

Compared To Synthetic Controls, INT230-6 Alone Extended Survival In Refractory Soft Tissue Sarcoma Subjects by Nearly 450 Days With Favorable Safety INT230-6, a Locally Delivered Cytotoxic...

-- Patricia Mae Garcia Santos, MD, MS, receives annual Conquer Cancer-Women Leaders in Oncology "Women Who Conquer Cancer" Young Investigator Award -- -- Tafadzwa L. Chaunzwa, MD, MHS, receives...

The Howard Hughes Corporation® (NYSE: HHC) announced today that Chief Executive Officer David O'Reilly will participate in a presentation moderated by Anthony Paolone from JP Morgan at NAREIT's...

"Between Two Worlds" Awarded Grand Prize at Gala Event, 2023 Auggie Award Winners Also Announced SANTA CLARA, Calif., June 2, 2023 /PRNewswire/ -- Augmented World Expo (AWE), the leading series of...